» Articles » PMID: 35055330

The Interaction Among Microbiota, Epigenetic Regulation, and Air Pollutants in Disease Prevention

Overview
Journal J Pers Med
Date 2022 Jan 21
PMID 35055330
Authors
Affiliations
Soon will be listed here.
Abstract

Environmental pollutants can influence microbiota variety, with important implications for the general wellbeing of organisms. In subjects at high-risk of cancer, gut, and lung microbiota are distinct from those of low-risk subjects, and disease progression is associated with microbiota alterations. As with many inflammatory diseases, it is the combination of specific host and environmental factors in certain individuals that provokes disease outcomes. The microbiota metabolites influence activity of epigenetic enzymes. The knowledge of the mechanisms of action of environmental pollution now includes not only the alteration of the gut microbiota but also the interaction between different human microbiota niches such as the lung-gut axis. The epigenetic regulations can reprogram differentiated cells in response to environmental changes. The microbiota can play a major role in the progression and suppression of several epigenetic diseases. Accordingly, the maintenance of a balanced microbiota by monitoring the environmental stimuli provides a novel preventive approach for disease prevention. Metagenomics technologies can be utilized to establish new mitigation approaches for diseases induced by polluted environments. The purpose of this review is to examine the effects of particulate matter exposure on the progression of disease outcomes as related to the alterations of gut and lung microbial communities and consequent epigenetic modifications.

Citing Articles

Using In Vitro Models to Study the Interactions Between Environmental Exposures and Human Microbiota.

Cheng Q, Chen S Microorganisms. 2025; 13(2).

PMID: 40005610 PMC: 11857843. DOI: 10.3390/microorganisms13020247.


Korean Red Ginseng Attenuates Particulate Matter-Induced Senescence of Skin Keratinocytes.

Kang K, Piao M, Fernando P, Herath H, Yi J, Hyun J Antioxidants (Basel). 2023; 12(8).

PMID: 37627511 PMC: 10451201. DOI: 10.3390/antiox12081516.


Special Issue: "Role of MicroRNA in Cancer Development and Treatment".

Pulliero A, Izzotti A J Pers Med. 2022; 12(3).

PMID: 35330502 PMC: 8951822. DOI: 10.3390/jpm12030503.

References
1.
Zhang Y, Li S, Gan R, Zhou T, Xu D, Li H . Impacts of gut bacteria on human health and diseases. Int J Mol Sci. 2015; 16(4):7493-519. PMC: 4425030. DOI: 10.3390/ijms16047493. View

2.
Elder A, Oberdorster G . Translocation and effects of ultrafine particles outside of the lung. Clin Occup Environ Med. 2006; 5(4):785-96. DOI: 10.1016/j.coem.2006.07.003. View

3.
Kraemer S, Ramachandran A, Perron G . Antibiotic Pollution in the Environment: From Microbial Ecology to Public Policy. Microorganisms. 2019; 7(6). PMC: 6616856. DOI: 10.3390/microorganisms7060180. View

4.
Xie J, Jin L, He T, Chen B, Luo X, Feng B . Bacteria and Antibiotic Resistance Genes (ARGs) in PM from China: Implications for Human Exposure. Environ Sci Technol. 2018; 53(2):963-972. DOI: 10.1021/acs.est.8b04630. View

5.
Franklin B, Brook R, Pope 3rd C . Air pollution and cardiovascular disease. Curr Probl Cardiol. 2015; 40(5):207-38. DOI: 10.1016/j.cpcardiol.2015.01.003. View